Senti Biosciences Holdings, Inc. (SNTI)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 6 signals for Senti Biosciences Holdings, Inc.. Most notable: 2026-10-26: Filed 8-K disclosing material agreement, acquisition or disposition of assets; 2026-09-24: Filed 8-K disclosing director or officer change; 2026-10-27: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement, acquisition or disposition of assets
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-21 | Lu Timothy K | director | F | 157,312 | 0 | $0 |
| 2026-10-21 | Rajangam Kanya | officer | F | 19,953 | 0 | $0 |
| 2026-03-09 | Rajangam Kanya | officer | F | 10,757 | 0 | $0 |
| 2026-03-09 | Lu Timothy K | director | F | 80,666 | 0 | $0 |
| 2026-02-02 | Rajangam Kanya | officer | F | 1,384 | 0 | $0 |
| 2026-02-02 | Lu Timothy K | director | F | 4,191 | 0 | $0 |
| 2025-03-10 | Celadon Partners SPV 24 | ten percent owner | C | 9,777,000 | — | — |
| 2025-03-10 | Florence Anthony A. Jr. | ten percent owner | C | 3,333,000 | — | — |
| 2025-03-10 | Bayer US Holding LP | ten percent owner | C | 2,222,000 | — | — |
| 2025-03-10 | Rajangam Kanya | officer | C | 33,000 | 2.25 | $74,250 |
| 2025-03-07 | Rajangam Kanya | officer | A | 78,363 | 0 | $0 |
| 2025-03-07 | Lu Timothy K | director | A | 642,358 | 0 | $0 |
| 2025-02-06 | Lu Timothy K | director | S | 545 | 4.36 | $2,376 |
| 2025-02-06 | Rajangam Kanya | officer | S | 182 | 4.37 | $795 |
| 2025-02-04 | Lu Timothy K | director | S | 3,922 | 4.07 | $15,963 |
| 2025-02-04 | Rajangam Kanya | officer | S | 1,297 | 4.07 | $5,279 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-10-27 8-K
- 2026-10-26 8-K
- 2026-10-23 4
- 2026-10-23 4
- 2026-10-15 8-K
- 2026-10-13 8-K
- 2026-10-13 DEFA14A
- 2026-09-24 EFFECT
- 2026-09-24 PRER14A
- 2026-09-24 8-K
- 2026-09-24 424B3
- 2026-09-24 DEFM14A
- 2026-09-22 S-3/A
- 2026-09-11 SCHEDULE 13D/A
- 2026-09-10 S-3/A
- 2026-09-04 DEFA14A
- 2026-09-04 8-K
- 2026-09-04 PRER14A
- 2026-09-02 DEFA14A
- 2026-09-02 8-K